C155H184F7N25O22S — CID 159259189
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;N-[2-(2,3-dimethoxyphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[(2,3-dimethoxyphenyl)methyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[2-(3-ethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-phenylethyl)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-pyridin-3-ylethyl)piperidine-1-carboxamide;N-[1-(4-methylsulfonylphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;3-pyrazin-2-yl-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrrolidine-1-carboxamide (PubChem CID 159259189) has the molecular formula C155H184F7N25O22S and a molecular weight of 2914.38 g/mol. Its IUPAC name is N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;N-[2-(2,3-dimethoxyphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[(2,3-dimethoxyphenyl)methyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[2-(3-ethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-phenylethyl)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-pyridin-3-ylethyl)piperidine-1-carboxamide;N-[1-(4-methylsulfonylphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;3-pyrazin-2-yl-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrrolidine-1-carboxamide.
| Compound Name | N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;N-[2-(2,3-dimethoxyphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[(2,3-dimethoxyphenyl)methyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[2-(3-ethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-phenylethyl)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-pyridin-3-ylethyl)piperidine-1-carboxamide;N-[1-(4-methylsulfonylphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;3-pyrazin-2-yl-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrrolidine-1-carboxamide |
|---|---|
| PubChem CID | 159259189 |
| Molecular Formula | C155H184F7N25O22S |
| Molecular Weight | 2914.38 g/mol |
| Exact Mass | 2912.37 |
| IUPAC Name | N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;N-[2-(2,3-dimethoxyphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[(2,3-dimethoxyphenyl)methyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;N-[2-(3-ethoxyphenyl)ethyl]-4-(4-fluorophenoxy)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-phenylethyl)piperidine-1-carboxamide;4-(4-fluorophenoxy)-N-(2-pyridin-3-ylethyl)piperidine-1-carboxamide;N-[1-(4-methylsulfonylphenyl)ethyl]-3-pyrazin-2-ylpyrrolidine-1-carboxamide;3-pyrazin-2-yl-N-[[2-(trifluoromethoxy)phenyl]methyl]pyrrolidine-1-carboxamide |
| SMILES | CC(NC(=O)N1CCC(c2cnccn2)C1)c1ccc(S(C)(=O)=O)cc1.CCOc1cccc(CCNC(=O)N2CCC(Oc3ccc(F)cc3)CC2)c1.COc1ccc(CCNC(=O)N2CCC(Oc3ccc(F)cc3)CC2)cc1OC.COc1cccc(CCNC(=O)N2CCC(c3cnccn3)C2)c1OC.COc1cccc(CNC(=O)N2CCC(c3cnccn3)C2)c1OC.O=C(NCCc1ccccc1)N1CCC(Oc2ccc(F)cc2)CC1.O=C(NCCc1cccnc1)N1CCC(Oc2ccc(F)cc2)CC1.O=C(NCc1ccccc1OC(F)(F)F)N1CCC(c2cnccn2)C1 |
| InChI | InChI=1S/C22H27FN2O4.C22H27FN2O3.C20H23FN2O2.C19H22FN3O2.C19H24N4O3.C18H22N4O3S.C18H22N4O3.C17H17F3N4O2/c1-27-20-8-3-16(15-21(20)28-2)9-12-24-22(26)25-13-10-19(11-14-25)29-18-6-4-17(23)5-7-18;1-2-27-21-5-3-4-17(16-21)10-13-24-22(26)25-14-11-20(12-15-25)28-19-8-6-18(23)7-9-19;21-17-6-8-18(9-7-17)25-19-11-14-23(15-12-19)20(24)22-13-10-16-4-2-1-3-5-16;20-16-3-5-17(6-4-16)25-18-8-12-23(13-9-18)19(24)22-11-7-15-2-1-10-21-14-15;1-25-17-5-3-4-14(18(17)26-2)6-8-22-19(24)23-11-7-15(13-23)16-12-20-9-10-21-16;1-13(14-3-5-16(6-4-14)26(2,24)25)21-18(23)22-10-7-15(12-22)17-11-19-8-9-20-17;1-24-16-5-3-4-13(17(16)25-2)10-21-18(23)22-9-6-14(12-22)15-11-19-7-8-20-15;18-17(19,20)26-15-4-2-1-3-12(15)9-23-16(25)24-8-5-13(11-24)14-10-21-6-7-22-14/h3-8,15,19H,9-14H2,1-2H3,(H,24,26);3-9,16,20H,2,10-15H2,1H3,(H,24,26);1-9,19H,10-15H2,(H,22,24);1-6,10,14,18H,7-9,11-13H2,(H,22,24);3-5,9-10,12,15H,6-8,11,13H2,1-2H3,(H,22,24);3-6,8-9,11,13,15H,7,10,12H2,1-2H3,(H,21,23);3-5,7-8,11,14H,6,9-10,12H2,1-2H3,(H,21,23);1-4,6-7,10,13H,5,8-9,11H2,(H,23,25) |
| InChIKey | KWHCWNIDCKMDPV-UHFFFAOYSA-N |
| XLogP | 23.94 |
| TPSA | 519.63 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 43 |
| Heavy Atoms | 210 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2914.38 |
| LogP ≤ 5 | 23.94 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 31 |